Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Rebbeck

Showing results (111-120 of 416) with videos related to

Pageof 42
Sort By:
Carcinogenesis|November 26, 2008
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American womenTimothy R Rebbeck, Angela DeMichele, Teo V Tran, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 2025
Opportunities to Avoid Invasive Cancer by Diagnosis and Interception of Preneoplastic Lesions and Cancer Risk ConditionsPranoti Pradhan, Irene M Ghobrial, Catherine R Marinac, et al.
JAMA|February 12, 2019
Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015Brandon A Mahal, Santino Butler, Idalid Franco, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goalTimothy R Rebbeck, Powel H Brown, Ernest T Hawk, et al.
BMC Cancer|July 31, 2016
The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancerKosj Yamoah, Charnita M Zeigler-Johnson, Abra Jeffers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approachPeter A Kanetsky, Fan Ge, Derek Najarian, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goalTimothy R Rebbeck, Powel H Brown, Ernest T Hawk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2025
Cross-sectional Associations of Neighborhood Social and Environmental Contextual Factors with Telomere Length in Male and Female Health ProfessionalsHari S Iyer, Timothy R Rebbeck, Elise G Elliott, et al.
Prostate Cancer|October 24, 2012
Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese MenPedro Fernandez, Charnita M Zeigler-Johnson, Elaine Spangler, et al.
JCO Global Oncology|October 17, 2022
Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology GapParsa Erfani, Michael Bates, Pat Garcia-Gonzalez, et al.
Pageof 42

Showing results (111-120 of 416) with videos related to

Sort By:
Pageof 42
Carcinogenesis|November 26, 2008
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American womenTimothy R Rebbeck, Angela DeMichele, Teo V Tran, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 2025
Opportunities to Avoid Invasive Cancer by Diagnosis and Interception of Preneoplastic Lesions and Cancer Risk ConditionsPranoti Pradhan, Irene M Ghobrial, Catherine R Marinac, et al.
JAMA|February 12, 2019
Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015Brandon A Mahal, Santino Butler, Idalid Franco, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goalTimothy R Rebbeck, Powel H Brown, Ernest T Hawk, et al.
BMC Cancer|July 31, 2016
The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancerKosj Yamoah, Charnita M Zeigler-Johnson, Abra Jeffers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approachPeter A Kanetsky, Fan Ge, Derek Najarian, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goalTimothy R Rebbeck, Powel H Brown, Ernest T Hawk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2025
Cross-sectional Associations of Neighborhood Social and Environmental Contextual Factors with Telomere Length in Male and Female Health ProfessionalsHari S Iyer, Timothy R Rebbeck, Elise G Elliott, et al.
Prostate Cancer|October 24, 2012
Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese MenPedro Fernandez, Charnita M Zeigler-Johnson, Elaine Spangler, et al.
JCO Global Oncology|October 17, 2022
Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology GapParsa Erfani, Michael Bates, Pat Garcia-Gonzalez, et al.
Pageof 42